Pharmanest, Inc
Clinical trials sponsored by Pharmanest, Inc, explained in plain language.
-
Digital liver score may predict who gets sick
Knowledge-focused CompletedThis study looked at 1,578 people with a type of fatty liver disease called MASLD. Researchers used a computer program to analyze liver biopsy images and calculate a score called Ph-FCS. The goal was to see if this score could predict who would later have serious liver complicati…
Sponsor: PharmaNest, Inc • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Digital biopsy score may predict liver failure risk in MASLD patients
Knowledge-focused CompletedThis study looked at whether a computer analysis of liver biopsy images (called FibroNest Ph-FCS) can predict serious liver complications in people with a type of fatty liver disease called MASLD. Researchers reviewed data from 1,241 adults who had a liver biopsy and were followe…
Sponsor: PharmaNest, Inc • Aim: Knowledge-focused
Last updated May 04, 2026 16:19 UTC